|
3819 days since CGAB 501 (06/09/2014)
|
|
|
JME |
: John Essigmann |
|
RS |
: Ram Sasisekharan |
|
UN |
: Uma Narayanasami |
|
MF |
: Mayuree Fuangthong |
| Date/Time | Topics | Lecturer |
|---|---|---|
| Mon 09 Jun 2014 09:00 - 12:00 | L1: Molecular Level: Central Dogma & Replication -Central dogma and nucleic acid structure -DNA Replication | MF |
| Wed 11 Jun 2014 09:00 - 12:00 | L2: Molecular Level: Transcription • Transcription machinery • Transcription regulation | MF |
| Fri 13 Jun 2013 09:00 - 12:00 | L3: Molecular Level: Translation • Translation machinery • Stages in translation | MF |
| Mon 16 Jun 2014 09:00 - 12:00 | L4: Molecular Level: Spontaneous and Induced Mutations as Drivers of Evolution • Introduction into Core Curriculum and CGAB501: The MIT perspective • Research paper topic: Inflammation and Cancer • Example: Hepatitis B and Aflatoxin (which will be covered in more detail later) | JME |
| 13:00 - 16:00 | Review 1 | MF |
| Wed 18 Jun 2014 09:00 - 12:00 | L5: Molecular Level: Spontaneous and Induced Mutations as Drivers of Evolution • Spontaneous and induced mutations • Mutator phenotype and cancer | JME |
| Fri 20 Jun 2014 09:00 - 12:00 | L6: Molecular Level: MMR and Evolution • Mismatch repair and fast forward evolution • Drug resistance driven by fast evolution • Paper analysis (Arkin; Loeb) | JME |
| Mon 23 Jun 2014 09:00 - 12:00 | L7: Molecular Level: Cancer • Six steps of malignant transformation • How conventional anticancer drugs target molecular pathways • Review of molecular pathways of growth and energy metabolism • Recent advances showing that specific metabolic networks of cancer cells determine susceptibility to anticancer agents | JME |
| 13:00 - 16:00 | Review 2 | JME/MF/TA |
| Wed 25 Jun 2014 09:00 - 12:00 | L8: Molecular Level: Cancer • Metabolic networks of cancer and other growing cells • Paper analysis (Ditsworth, Dawson) | JME |
| Fri 27 Jun 2014 09:00 - 12:00 | L9: Cell Level: Innate Immunity 1 • Activation of innate immune system accelerates cancer development • Chemistry of inflammation | JME |
| Mon 30 Jun 2014 09:00 - 12:00 | L10: Cell Level: Innate Immunity 2 • Activation of innate immune system accelerates cancer development • Chemistry of inflammation | JME |
| Tue 1 Jul 2014 09:00 - 12:00 | Review 3 | JME |
| Wed 2 Jul 2014 09:00 - 12:00 | L11: Cell Level to Organ Level • Aflatoxin carcinogenesis as a paradigm in which inflammation by an infectious agent (Hepatitis B) accelerates cancer initiated by a chemical (Aflatoxin) | JME |
| Fri 4 Jul 2014 09:00 - 12:00 | L12: Synergy and sensitivity modulation in biological networks | JME |
| Tue 15 Jul 2014 09:00 - 12:00 | L13: How to Identify a Functional Biomarker: A Case Study Involving Aflatoxin B1 and HBV | SC |
| Mon 21 Jul 2014 09:00 - 12:00 | Exam I | Staff |
| Tue 22 Jul 2014 13:00 - 16:00 | L14: Cells to Tissues • Extracellular Matrix | RS |
| Wed 23 Jul 2014 09:00 - 12:00 | L15: Cancer at the Clinical Level • Hematology and Oncology | UN |
| Fri 25 Jul 2014 09:00 - 12:00 | L16: Cancer at the Clinical Level | UN |
| Mon 28 Jul 2014 09:00 - 12:00 | L17: Cancer at the Clinical Level | UN |
| Wed 30 Jul 2014 09:00 - 12:00 | L18: Cancer at the Clinical Level | UN |
| Fri 01 Aug 2014 09:00 - 12:00 | L19: Cancer at the Clinical Level | UN |
| Late Aug 09:00 - 12:00 | Proposal Presentation I | Staff |
| Late Sep 09:00 - 12:00 | Proposal Presentation II | Staff |
| Late Oct 13:00 - 16:00 | Proposal Presentation III | Staff |
| Mon 18 Aug 2014 09:00 - 12:00 | Exam II | Staff |